Skip to main content

Table 2 Effects of polyethylene glycosylated (PEGylated) porcine glucagon-like peptide-2 (pGLP-2) on growth performance of colitis rats

From: Therapeutic effects of different doses of polyethylene glycosylated porcine glucagon-like peptide-2 on ulcerative colitis in male rats

Groups Body weight change, % Intestinal length, cm Colonic length, cm Intestinal weight (mg)/body weight (g) Colonic weight (mg)/body weight (g)
Control 30.48 ± 3.44a 94.72 ± 4.93 15.69 ± 1.90a 30.61 ± 2.22 11.19 ± 1.90b
Dextran sodium sulphate (DSS) 11.90 ± 5.04c 92.88 ± 9.78 12.40 ± 1.94b 35.19 ± 1.22 9.15 ± 1.79b
DSS + PEG–pGLP-2(L) 21.45 ± 2.00b 94.50 ± 7.07 14.74 ± 1.90a 34.51 ± 3.09 14.13 ± 2.77a
DSS + PEG–pGLP-2(M) 21.46 ± 4.65b 99.10 ± 8.03 14.48 ± 1.42ab 38.91 ± 4.23 14.22 ± 0.38a
DSS + PEG–pGLP-2(H) 20.63 ± 3.4b 99.56 ± 6.82 13.42 ± 0.80ab 35.87 ± 1.73 11.52 ± 0.64b
  1. Data are expressed as means ± SD; no significant difference exists in that with no letter or the same letters (p > 0.05), and different letters (p < 0.05) indicate statistically significant difference